Javascript must be enabled to continue!
P-1838. Improving Hepatitis C Virus Screening for Adults in a Safety-net Primary Care Clinic
View through CrossRef
Abstract
Background
The Centers for Disease Control and Prevention (CDC) recommends universal screening for hepatitis C among all adults aged 18 to 79 irrespective of risk factors. Given the absence of a preventive vaccine, early diagnosis is the best way to prevent complications such as liver failure and cirrhosis. The goal of our quality improvement project was to increase the percentage of hepatitis C screening in our primary care clinic patients aged 18 to 79 from a baseline of 74% to 80% between May 2024 and May 2025.Hepatitis C Screening Percentage By MonthImproving Hepatitis C Virus Screening for Adults in a Safety-net Primary Care Clinic
Methods
The presence of hepatitis C screening serology in all eligible individuals presenting to the primary care clinic at our urban safety-net hospital was evaluated monthly through electronic chart reviews. For PDSA cycle 1, in May 2024, a red-text Smartphrase for hepatitis C screening was added to the ambulatory clinic note template, prompting providers to review and fill out hepatitis C screening status before signing the note. PDSA cycle 2, in August 2024, involved educating residents about hepatitis C screening. PDSA cycle 3 started in November 2024 and involved sending monthly reminder emails to providers who missed hepatitis C screening for eligible patients. During PDSA cycle 4, in December 2024, provider education was implemented during monthly ambulatory care meetings. The importance of hepatitis C screening regardless of risk factors was emphasized. PDSA cycle 5, in January 2025, focused on patients’ awareness: patients were sent reminders about their unscreened hepatitis C status via MyChart application.
Results
After PDSA 1, the percentage of eligible patients screened for Hepatitis C decreased from 74% to 70%, and it further decreased to 68% after PDSA 2. This result is not entirely surprising since education alone in Quality Improvement is known to be at best modestly effective and temporary. After PDSA 3, the screened percentage increased to 80% and further increased to 84% after PDSA 4 and 87% after PDSA 5.
Conclusion
In our project, outcomes improved following the reinforcement of hepatitis C screening guidelines during monthly meetings. Prior to this project, providers were screening only high-risk individuals, but after providing education on the updated guidelines and implementing monthly email notifications, we exceeded our goal.
Disclosures
All Authors: No reported disclosures
Oxford University Press (OUP)
Title: P-1838. Improving Hepatitis C Virus Screening for Adults in a Safety-net Primary Care Clinic
Description:
Abstract
Background
The Centers for Disease Control and Prevention (CDC) recommends universal screening for hepatitis C among all adults aged 18 to 79 irrespective of risk factors.
Given the absence of a preventive vaccine, early diagnosis is the best way to prevent complications such as liver failure and cirrhosis.
The goal of our quality improvement project was to increase the percentage of hepatitis C screening in our primary care clinic patients aged 18 to 79 from a baseline of 74% to 80% between May 2024 and May 2025.
Hepatitis C Screening Percentage By MonthImproving Hepatitis C Virus Screening for Adults in a Safety-net Primary Care Clinic
Methods
The presence of hepatitis C screening serology in all eligible individuals presenting to the primary care clinic at our urban safety-net hospital was evaluated monthly through electronic chart reviews.
For PDSA cycle 1, in May 2024, a red-text Smartphrase for hepatitis C screening was added to the ambulatory clinic note template, prompting providers to review and fill out hepatitis C screening status before signing the note.
PDSA cycle 2, in August 2024, involved educating residents about hepatitis C screening.
PDSA cycle 3 started in November 2024 and involved sending monthly reminder emails to providers who missed hepatitis C screening for eligible patients.
During PDSA cycle 4, in December 2024, provider education was implemented during monthly ambulatory care meetings.
The importance of hepatitis C screening regardless of risk factors was emphasized.
PDSA cycle 5, in January 2025, focused on patients’ awareness: patients were sent reminders about their unscreened hepatitis C status via MyChart application.
Results
After PDSA 1, the percentage of eligible patients screened for Hepatitis C decreased from 74% to 70%, and it further decreased to 68% after PDSA 2.
This result is not entirely surprising since education alone in Quality Improvement is known to be at best modestly effective and temporary.
After PDSA 3, the screened percentage increased to 80% and further increased to 84% after PDSA 4 and 87% after PDSA 5.
Conclusion
In our project, outcomes improved following the reinforcement of hepatitis C screening guidelines during monthly meetings.
Prior to this project, providers were screening only high-risk individuals, but after providing education on the updated guidelines and implementing monthly email notifications, we exceeded our goal.
Disclosures
All Authors: No reported disclosures.
Related Results
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
To evaluate the factors determining the severity of chronic hepatitis B virus infection and the interactions of human immunodeficiency virus and hepatitis delta virus infections, w...
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
We longitudinally studied 51 patients from two hemodialysis centers to determine the prevalence of hepatitis C virus infection in hemodialysis patients. Serum samples were tested f...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Association of poor virus specific immunoglobulin G antibody responses with higher viral load is seen in Bangladeshi pregnant women having acute Hepatitis E Genotype 1 infection
Association of poor virus specific immunoglobulin G antibody responses with higher viral load is seen in Bangladeshi pregnant women having acute Hepatitis E Genotype 1 infection
Abstract
Although Hepatitis E viral illness is usually self-limiting, higher rates of morbidity and mortality are frequently observed during pregnancy in South Asia...
Changes in Hepatitis C Awareness in Different Disciplines During COVID-19
Changes in Hepatitis C Awareness in Different Disciplines During COVID-19
Background: We aimed to determine the awareness of referring hepatitis C virus patients to the relevant departments and the effect of the pandemic period on this subject. Methods: ...

